Analyst Recommendations

Bernstein analyst issues OUTPERFORM recommendation for ZS on March 1, 2024 08:14AM ET. The previous analyst recommendation was Outperform.ZS was trading at $241.97 at issue of the analyst...

March 1, 2024   ZS 2.82%

Barclays analyst issues BUY recommendation for SOUN on March 1, 2024 08:14AM ET. The previous analyst recommendation was Buy.SOUN was trading at $7.42 at issue of the analyst...

March 1, 2024   SOUN -2.06%

Sidoti & Co. analyst issues UNDERPERFORM recommendation for ROE on March 1, 2024 09:00AM ET. The previous analyst recommendation was Underperform.ROE was trading at $0 at issue of...

March 1, 2024   ROE 1.06%

Stifel Nicolaus analyst issues BUY recommendation for MYRG on March 1, 2024 09:00AM ET. The previous analyst recommendation was Buy.MYRG was trading at $162.46 at issue of the...

March 1, 2024   MYRG 3.04%

Needham analyst issues UNDERPERFORM recommendation for EXLS on March 1, 2024 09:00AM ET. The previous analyst recommendation was Underperform.EXLS was trading at $31.12 at issue of the analyst...

March 1, 2024   EXLS 0.03%

Wedbush analyst issues BUY recommendation for EXLS on March 1, 2024 09:00AM ET. The previous analyst recommendation was Buy.EXLS was trading at $31.12 at issue of the analyst...

March 1, 2024   EXLS 0.03%

Cowen & Co. analyst issues OUTPERFORM recommendation for GDRX on March 1, 2024 08:23AM ET. The previous analyst recommendation was Outperform.GDRX was trading at $7.79 at issue of...

March 1, 2024   GDRX -1.05%

Barclays analyst issues OVERWEIGHT recommendation for GDRX on March 1, 2024 08:23AM ET. The previous analyst recommendation was Overweight.GDRX was trading at $7.79 at issue of the analyst...

March 1, 2024   GDRX -1.05%

Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for AMGN on March 1, 2024 07:52AM ET. The previous analyst recommendation was Equal-Weight.AMGN was trading at $273.83 at issue of the...

March 1, 2024   AMGN -1.68%

Oppenheimer analyst issues PERFORM recommendation for ABBV on March 1, 2024 07:52AM ET. The previous analyst recommendation was Perform.ABBV was trading at $176.05 at issue of the analyst...

March 1, 2024   ABBV -1.60%